The digital press release with multimedia content can be accessed here:
Britain's National Institute for Health and Care Excellence ((NICE)), the advisor to the National Health Service ((NHS)) on costs and care quality, is now
Financing supports near-term initiation of Phase 2 trials in essential tremor and spinocerebellar ataxia (Image: Cadent Therapeutics).
Novartis (NYSE:NVS) has taken a non-exclusive licence to Celyad (NASDAQ:CYAD) granted allogeneic US patent for $96m (an upfront fee, we assume $12m, and milestones) plus...
BioLineRX Ltd (NASDAQ:BLRX) is currently focused on the development of BL-8040, which is a short peptide antagonist for CXCR4, a chemokine receptor involved with tumor progression,...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) posted a loss of $3.61 per share in the first quarter of 2017, narrower than the Zacks Consensus Estimate of a loss of $4.27 and...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Buy||Strong Buy||Strong Sell||Sell||Strong Buy|
|Summary||Strong Buy||Neutral||Sell||Neutral||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Outside Up||30||3||Nov 16, 2018 10:00AM|
|Bullish Engulfing||1W||4||Oct 14, 2018|
|Bullish Engulfing||30||4||Nov 16, 2018 09:30AM|
Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.Read More
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$2000||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.